secwatch.observer — SEC 8-K summary
======================================

Issuer:     Armata Pharmaceuticals, Inc. (ARMP)
CIK:        0000921114
Form:       8-K
Filed at:   2022-03-28T23:59:59+00:00
Accession:  0001104659-22-038851
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Armata CFO Steve Martin to retire June 30; Erin Butler named successor as CFO & VP Finance
--------------------------------------------------------------------------------

- CFO Steve R. Martin to retire effective June 30, 2022; will serve as advisor through Dec 31, 2022.
- Martin to receive continued base salary ($389,340/yr) during transition; half of unvested options to vest at end.
- Erin Butler appointed VP Finance & Admin (April 1) and Principal Financial & Accounting Officer (July 1).
- Butler's compensation: $290K base salary, 30% target bonus, option for 50,000 shares vesting over 4 years.
- Butler to get 6 months severance on involuntary termination; full equity acceleration on change in control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/921114/000110465922038851/0001104659-22-038851-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/921114/000110465922038851/tm2210607d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-038851

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer